Abstract:Mitochondria are an essential intracellular organelle for medication targeting and delivery since they seem to create energy and conduct many other cellular tasks, and mitochondrial dysfunctions and malfunctions lead to many illnesses. Many initiatives have been taken to detect, diagnose, and image mitochondrial abnormalities, and to transport and accumulate medicines precisely to mitochondria, all because of special mitochondrial aspects of the pathophysiology of cancer. In addition to the negative membrane potential and paradoxical mitochondrial dynamics, they include high temperatures, high levels of reactive oxygen species, high levels of glutathione, and high temperatures. Neurodegenerative diseases represent a broad spectrum of debilitating illnesses. They are linked to the loss of certain groups of neurons based on an individual's physiology or anatomy. The mitochondria in a cell are generally accepted as the authority with respect to ATP production. Disruption of this system is linked to several cellular physiological issues. The development of neurodegenerative disorders has been linked to mitochondrial malfunction, according to pathophysiological studies. There seems to be substantial evidence connecting mitochondrial dysfunction and oxidative stress to the development of neurodegenerative disorders. It has been extensively observed that mitochondrial malfunction triggers autophagy, which plays a role in neurodegenerative disorders. In addition, excitotoxicity and mitochondrial dysfunction have been linked to the development of neurodegenerative disorders. The pathophysiology of neurodegenerative illnesses has been linked to increased apoptosis and necrosis, as well as mitochondrial malfunction. A variety of synthetic and natural treatments have shown efficacy in treating neurodegenerative illnesses caused by mitochondrial failure. Neurodegenerative illnesses can be effectively treated with existing drugs that target mitochondria, although their precise formulations are poorly understood. Therefore, there is an immediate need to focus on creating drug delivery methods specifically targeted at mitochondria in the treatment and diagnosis of neurodegenerative disorders.

Mitochondria-Targeted Drugs

Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

Mitochondrial-Targeted Drug and DNA Delivery

Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment

Mitochondrial-targeted liposome-based drug delivery – therapeutic potential and challenges

Targeting mitochondrial quality control: new therapeutic strategies for major diseases

Mitochondrial Targets for Pharmacological Intervention in Human Disease

Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives

[Mitochondrial therapy: a new strategy for treating mitochondrion-associated diseases]

The Role of Mitochondria-Targeted Antioxidant MitoQ in Neurodegenerative Disease

The Role of Mitochondria in Cellular Toxicity As a Potential Drug Target

Recent advances in mitochondria-targeting theranostic agents

Targeted Mitochondrial Nanomaterials in Biomedicine: Advances in Therapeutic Strategies and Imaging Modalities

Revitalizing Ancient Mitochondria with Nano-Strategies: Mitochondria-Remedying Nanodrugs Concentrate on Disease Control

Targeting Cancer Cell Mitochondria As a Therapeutic Approach.

Recent Advances in Chemical Biology of Mitochondria Targeting

Mitochondrial Targeting of Probes and Therapeutics to the Powerhouse of the Cell

Targeting Cancer Cell Mitochondria As a Therapeutic Approach: Recent Updates

Mitochondrial dysfunction: mechanisms and advances in therapy

The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease

Targeted Treatment Strategies for Mitochondria Dysfunction: Correlation with Neurological Disorders